I agree mate.. Especially with timing apparently being the reason receipts were lower (meaning Oct looking good). Let's see what Wayne comes up with.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025